The drug development process involves several stages, including drug discovery, preclinical testing, clinical trials, regulatory approval, and commercialization.
The drug development process can take 10-15 years or more, and only a small percentage of drugs that enter clinical trials are eventually approved for commercialization.
The drug development process can take 10-15 years or more, and only a small percentage of drugs that enter clinical trials are eventually approved for commercialization.
Good Manufacturing Practice (GMP) is a set of quality control standards that must be followed by pharmaceutical companies to ensure that their products are consistently manufactured to the highest quality standards.
A patent is a legal protection granted by a government that gives the inventor exclusive rights to manufacture, use, and sell an invention for a certain period of time.
Pharmacovigilance is the practice of monitoring the safety of drugs and other medicinal products and taking action to prevent or minimize adverse drug reactions and other safety concerns.
A clinical trial is a research study that involves human participants to evaluate the safety and efficacy of a new drug or medical intervention.
A drug interaction occurs when one drug affects the way another drug is metabolized or excreted, potentially leading to unwanted side effects or reduced efficacy of one or both drugs.
A generic drug is a drug that is equivalent to a brand-name drug in terms of active ingredients, dosage form, strength, route of administration, and therapeutic effect, but is sold under a different name.
A biologic drug is a drug made from living cells or organisms, rather than chemical synthesis. Biologic drugs are used to treat a wide range of diseases, including cancer, autoimmune disorders, and rare genetic diseases.
A pharmaceutical company is a company that researches, develops, and manufactures drugs and other medicinal products for the treatment of diseases and medical conditions..